The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...

The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused ...

HHS Secretary Robert F. Kennedy Jr. says Moderna (MRNA) has agreed to do another clinical trial to back its newly approved ...

Moderna Inc. has agreed to do a placebo-controlled trial of its new COVID vaccine that was recently approved by U.S.

Moderna has announced FDA approval for its new COVID-19 vaccine, mNexspike (mRNA-1283). This next-generation shot targets a specific part of the SARS-CoV-2 spike protein and requires only one-fifth ...

With U.S. recommendations for COVID-19 vaccines in flux, a leading member of the CDC's COVID vaccine advisory group is ...

Axsome (AXSM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Sanofi and BMS paid big money for rare disease and cancer assets, while Regeneron got in the obesity game; AstraZeneca, Gilead and Amgen shone at ASCO; RFK Jr. and the CDC appeared to disagree over ...

The industry is facing challenges from the new administration that could have serious impacts on everything from market ...

PEACHTREE CORNERS, GA and INDIANAPOLIS, IN / ACCESS Newswire / June 4, 2025 / Peachtree Corners – one of the United States’ ...